# Larimar Therapeutics, Inc.: Form 8-K, filed Jul 25, 2023

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2023-07-25
- Accepted by EDGAR: Jul 25, 2023, 11:02 ET
- Period: 2023-07-25
- Accession: 0000950170-23-034217
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000095017023034217/lrmr-20230725.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000095017023034217/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000095017023034217/lrmr-20230725.htm

Filed Jul 25, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-034217. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.